We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
AUM
$4B
AUM Growth
-$1.25B
Cap. Flow
-$1.28B
Cap. Flow %
-32.02%
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487

Sector Composition

Rank Sector Weight
1 Healthcare 1.79%
2 Communication Services 1.57%
3 Technology 1.13%
4 Consumer Discretionary 1.05%
5 Financials 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OUST icon
326
CALL
Ouster
OUST
$2.39B
$2.69M 0.07%
+31,670
New +$3.92M
TVRD
327
CALL
Tvardi Therapeutics
TVRD
$19.7M
$2.69M 0.07%
+3,444
New +$2.36M
UBER icon
328
CALL
Uber
UBER
$143B
$2.69M 0.07%
49,300
+7,300
+17% +$407K
IONS icon
329
CALL
Ionis Pharmaceuticals
IONS
$8.81B
$2.67M 0.07%
59,300
-10,700
-15% -$597K
RCL icon
330
PUT
Royal Caribbean
RCL
$86.1B
$2.65M 0.07%
31,000
-157,000
-84% -$12.4M
ZEN
331
CALL
DELISTED
ZENDESK INC
ZEN
$2.65M 0.07%
20,000
+10,000
+100% +$1.43M
MU icon
332
PUT
Micron Technology
MU
$988B
$2.65M 0.07%
+30,000
New +$2.55M
THBR
333
CALL
DELISTED
Thunder Bridge Acquisition II, Ltd. Class A Ordinary Shares
THBR
$2.6M 0.07%
+250,000
New +$2.9M
VIEW
334
CALL
DELISTED
View, Inc. Class A Common Stock
VIEW
$2.6M 0.07%
5,855
+4,188
+251% +$2.6M
AUPH icon
335
PUT
Aurinia Pharmaceuticals
AUPH
$1.93B
$2.6M 0.06%
200,000
-150,000
-43% -$2.18M
FSLY icon
336
CALL
Fastly Inc
FSLY
$3.37B
$2.59M 0.06%
+38,500
New +$3.31M
AGIO icon
337
CALL
Agios Pharmaceuticals
AGIO
$1.95B
$2.58M 0.06%
50,000
+35,000
+233% +$1.73M
SWK icon
338
CALL
Stanley Black & Decker
SWK
$14.9B
$2.58M 0.06%
12,900
VIR icon
339
CALL
Vir Biotechnology
VIR
$1.5B
$2.56M 0.06%
+50,000
New +$2.69M
AUPH icon
340
CALL
Aurinia Pharmaceuticals
AUPH
$1.93B
$2.54M 0.06%
196,000
-169,500
-46% -$2.46M
MSOS icon
341
PUT
AdvisorShares Pure US Cannabis ETF
MSOS
$854M
$2.54M 0.06%
+60,000
New +$2.77M
JD icon
342
PUT
JD.com
JD
$43.6B
$2.53M 0.06%
30,000
+5,000
+20% +$458K
UTHR icon
343
CALL
United Therapeutics
UTHR
$26.2B
$2.51M 0.06%
15,000
UTHR icon
344
PUT
United Therapeutics
UTHR
$26.2B
$2.51M 0.06%
15,000
OMER icon
345
Omeros
OMER
$863M
$2.49M 0.06%
140,000
+100,000
+250% +$1.94M
MLCO icon
346
PUT
Melco Resorts & Entertainment
MLCO
$2.24B
$2.49M 0.06%
125,000
VG
347
CALL
DELISTED
Vonage Holdings Corporation
VG
$2.49M 0.06%
+210,400
New +$2.74M
FUN icon
348
CALL
Cedar Fair
FUN
$1.81B
$2.48M 0.06%
+50,000
New +$2.28M
FATE icon
349
CALL
Fate Therapeutics
FATE
$293M
$2.47M 0.06%
+30,000
New +$2.87M
AAPL icon
350
Apple
AAPL
$4.9T
$2.44M 0.06%
20,000
-500
-2% -$64.2K

Similar funds

SG3 Management's Q1 2021 Portfolio in Review

As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.

Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.

  • SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
  • SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
  • SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
  • SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
  • SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
  • SG3 Management opened 626 new positions and closed 487 in Q1 2021.
  • SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.

Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.